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Bone morphogenetic proteinCardiomyocytes (CMs) derived from human pluripotent stem cells (hPSCs) offer immense value in studying
cardiovascular regenerativemedicine. However, intrinsic biases and differential responsiveness of hPSCs towards
cardiac differentiation pose signiﬁcant technical and logistic hurdles that hamper human cardiomyocyte studies.
Tandem modulation of canonical and non-canonical Wnt signaling pathways may play a crucial role in cardiac
development that can efﬁciently generate cardiomyocytes from pluripotent stem cells. Our Wnt signaling ex-
pression proﬁles revealed that phasicmodulation of canonical/non-canonical axis enabled orderly recapitulation
of cardiac developmental ontogeny. Moreover, evaluation of 8 hPSC lines showedmarked commitment towards
cardiac-mesoderm during the early phase of differentiation, with elevated levels of canonical Wnts (Wnt3 and
3a) and Mesp1. Whereas continued activation of canonical Wnts was counterproductive, its discrete inhibition
during the later phase of cardiac differentiation was accompanied by signiﬁcant up-regulation of non-
canonical Wnt expression (Wnt5a and 11) and enhanced Nkx2.5+ (up to 98%) populations. These Nkx2.5+
populations transited to contracting cardiac troponin T-positive CMs with up to 80% efﬁciency. Our results
suggest that timely modulation of Wnt pathways would transcend intrinsic differentiation biases of hPSCs to
consistently generate functional CMs that could facilitate their scalable production for meaningful clinical
translation towards personalized regenerative medicine.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Human pluripotent stem cells (hPSCs) such as embryonic stem cells
(hESC) and induced pluripotent stem cells (hiPSC) proliferate indeﬁnite-
ly in undifferentiated state, but can be induced to produce various useful
cell types to enable widespread clinical applications [1]. However, intrin-
sic biases of these hPSCs and their inherent responses to induction factors
often yielded inconsistent differentiation outcomes [2,3]. This presents a
formidable obstacle in generation of large quantities of desired cell types
such as cardiomyocytes (CMs) that are essential for regenerative therapy,
disease modeling and drug screening [4–10].
Bone morphogenetic proteins (BMPs) and Wnt family are critically
important in heart formation in developing embryos [11–13]. BMPsh Institute Singapore, National
Singapore. Tel.: +65 65365357;
h Institute Singapore, National
Singapore. Tel.: +65 64350752;
ta),are involved in varying stages of cardiac commitment [11,13] and their
interaction with Wnts completes a highly complex molecular network
in cardiac developmental ontogeny [12]. The classical canonical Wnt
pathway involves β-catenin mediated signaling that is crucial for early
cardiac development/commitment [14–16] while the non-canonical
Wnt pathway involves JNK and Ca2+-dependent signaling that regulate
subsequent cardiac speciﬁcation [12,15]. This suggests that tandem
signaling relay amongWntmembers is a key to efﬁcient cardiac differen-
tiation of hPSCs.
In order to improve efﬁciency, co-culture with END2 cell line/
conditioned media or temporal addition of recombinant cytokine cock-
tails has been implemented to recapitulate early cardiac developmental
ontogeny [17–19]. However, differential thresholds for fate commitment
in disparate hPSC lines necessitate a tedious titration of inducing factors
(e.g. Activin A and BMP) in a dose-and time-dependent manner to
individually optimize their cardiac differentiation [20]. Recently, small
molecules have emerged as promising alternatives to replacing costly
recombinant cytokine cocktails for directing cardiac differentiation
[21]. We and others have shown that small molecules, including p38
MAPK signaling inhibitors andWNT signaling inhibitors promote cardiac
differentiation in the absence of recombinant cytokine cocktails, albeit
with greatly varied efﬁciencies (10–60%) [1,7,22–24]. We hypothesize
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signaling in a phase-speciﬁc manner is pivotal to efﬁcient cardiac differ-
entiation of hPCSs.
In this study, we consistently differentiate eight differentially
derived hPSC lines (1 hESC line and 7 hiPSC lines) into CMs efﬁciently
by modulating Wnts along with BMP signaling. Our results suggest
thatWnts play a role in regulating cardiogenesis in hPSC differentiation
whereby timelymodulation of canonical and non-canonicalWnt signal-
ing may inﬂuence cardiac differentiation efﬁciency. These results
provide a better understanding of cardiac differentiation that could
explain inconsistencies associated with intrinsic biases within various
pluripotent stem cell lines.
2. Material and methods
2.1. Cell lines and maintenance
A total of 8 different pluripotent stem cell lines (1 hESC and 7 hiPSC)
were used in this study. Seven hiPSC lines were generated in-house or
obtained from different laboratories that were derived from ﬁbroblast
fromdifferent sources of normal or diseased patients and reprogrammed
by various methods. Human ES line, NKX2-5eGFP/w-hESCs obtained from
Dr. David Elliot, Murdoch Childrens Research Institute, Australia [25],
dermal ﬁbroblast-derived virally reprogrammed hiPSC lines from
Danon disease patients; Danon-hiPSC1 and Danon-hiPSC2, obtained
from Dr. Alan Colman, IMB, Singapore and BJ ﬁbroblast-derived-mRNA
reprogramed hiPSC line; BJ-hiPSC, obtained from Dr. Vinod Verma,
Experimental Therapeutic Centre, Singapore [45]. All other lines
were in-house generated by episomal based systems as previously re-
ported [1], these include, long QT syndrome 2 patient derived hiPSC;
LQTS2-hiPSC1.3 and LQTS2-hiPSC1.4 [26], normal atrial ﬁbroblast de-
rived hiPSC; AF-hiPSC and normal dermal ﬁbroblast derived hiPSC line,
DF-hiPSC4.
Human ES cells and iPS cells were maintained on 1% matrigel
(BD Biosciences, CA, USA) and grown in chemically deﬁned mTeSR1
medium (Stem Cell Technologies, VA, Canada) as described previously
[1]. Pluripotent stem cells were washed with DMEM-F12 (Invitrogen,
CA, USA) and incubated with 1 mg/ml dispase (Stem Cell Technologies,
VA, Canada) for 5–7 min, washed and colonies were scrapped. Con-
trolled tituration of the colonies was performed to get small clumps of
approximately 50–70 μm in size for re-plating on new matrigel coated
dishes (1:6 split ratios). Cells were fed dailywith freshmTeSR1medium
and passaged every 5–6 days and were maintained at 37 °C under 5%
CO2 in air at 95% humidity.
2.2. Cardiac differentiation
A schematic representation of the protocol with growth factors has
been shown in Fig. 1A. Brieﬂy, hiPSC/hESC lines were pre-treated with
10 μM Y27632 (Stem Cell Technologies, VA, Canada) for 4 h before
dissociating them to single cells with Accutase (Stem Cell Technologies,
VA, Canada). Cells were aggregated in spin EBs of 5000 cells/EB in
AggreWell™ 800 (Stem Cell Technologies, VA, Canada) in media A
(mTesR1: DMEM-F12-B27 (1:1) with 4 mg/mL PVA) with ascorbic
acid (284 μM) and BMP4 (770 pM) and centrifuged at 300 g for 5 min
and incubated overnight. Next day (day 1), EBs were harvested and col-
lected in low attachment dishes (Corning, USA) in medium B (mTesR1:
DMEM-F12-B27 (1:4) with 4 mg/mL PVA) with ascorbic acid (284 μM),
BMP4 (1.5 nM), Activin A (1.5 nM), SB203580 (5 μM) and FGF2
(3.1 nM) till day 4. Media were replaced with medium C (DMEM-F12-
B27 with 4 mg/mL PVA) along with ascorbic acid (284 μM),
SB203580 (5 μM), Noggin (4.3 nM), A83-01 (1 μM), VEGF (1.5 nM), Cy-
closporin A (2.5 μM) and IWP4 (10 μM) till day 6. For the last two days,
EBs were cultured in medium C along with ascorbic acid (284 μM),
SB203580 (5 μM), VEGF (521 pM), Cyclosporin A (2.5 μM) and IWP4
(10 μM). EBs were plated on day 8 in EB2 medium (DMEM-F12 with2% FBS) on 0.1% gelatin coated dishes. Beating areas were clearly
observed between days 10–18 depending on different cell lines and
cells were utilized for subsequent experiments.
2.3. Immunoﬂuorescence
Colonies of iPSC and single cells generated from beating clusters
were seeded on matrigel-and gelatin-coated glass slides respectively,
while whole EB staining were performed in suspension. All cell types
were ﬁxed with 4% paraformaldehyde, permeabilized with 1% Triton
X-100 (Sigma–Alrich, MO, USA) and blocked with 5% bovine serum
albumin (Sigma–Alrich, MO, USA). Human iPS colonies were stained
for 1 h with primary antibodies targeting pluripotency markers, Oct-4,
SSEA4, Tra-1-60 and Tra-1-80 (all Millipore, MA, USA), whereas
cardiomyocytes (CMs) were stained with primary antibodies, α-
actinin (Sigma–Alrich, MO, USA), cardiac troponin T (USBiologicals,
MA, USA), titin (DHSB, Iowa, USA), SERCA (Sigma–Alrich, MO, USA),
MLC2v (Synaptic Systems, Germany), MLC2a (Synaptic Systems,
Germany), Nkx2.5 (Novus Biologicals, CO, USA) and whole EBs with T,
Mesp1 (Abcam, MA, USA) and cTnT and NKx2.5. Samples were washed
and incubated with respective secondary antibodies (Invitrogen, CA,
USA) for 1 h and subsequently counterstained with DAPI. Slides were
examined under Zeiss LSM710 NLO multi-photon confocal microscope
(Carl Zeiss Inc, USA).
2.4. Flow cytometry
Human iPS-derived CM cultures or day 8 EBs were collected and
trypsinizedwith TrypLE (Invitrogen, CA, USA) for 5–7min to obtain sin-
gle cell suspension. Cells were washed with PBS and ﬁxed using ﬁx and
perm cell permeabilization reagent (Invitrogen, CA, USA), except for
Sirpa staining and incubated with either one of the antibodies, Sirpa
conjugated-PE (BD Biosciences), Nkx2.5 (Novus) and cardiac troponin
T (USBiologicals, MA, USA) for 1 h followed by incubationwith appropri-
ate Alexa ﬂour 488 or 350 conjugated secondary antibody (Invitrogen,
CA, USA). Samples were then acquired on FACS Aria II (BD Biosciences,
CA, USA) and the data were analyzed utilizing FlowJo ver 6.4 software.
A total of 10,000 gated events were counted for each marker in three
independent experiments.
2.5. Western blots
Differentiating cells fromall groupswere lysed in RIPA buffer (Thermo
Scientiﬁc, USA). Protein concentration was estimated using Pierce BCA
protein Assay kit as per themanufacturer's instruction (Thermo Scientiﬁc,
USA). Equal amounts of protein (20 μg) were loaded on a gradient 4–12%
Bis-Tris NuPage Gel (Life Technologies, USA) and run at 165 V for 35 min
and dry transferred to nitrocellulose (NC) membrane using iBlot (Life
Technologies, USA) as per manufacturer's instruction. NC membranes
were blocked with 5% BSA for 1 h and probed overnight with respective
primary antibodies, washed with 0.1% PBST (phosphate buffered saline
with tween20) andprobedwith respective secondary antibody conjugat-
edwith HRP (Amersham, USA) for 1 h.Membraneswerewashed and de-
veloped usingAmershamECL kit (Amersham,USA) as permanufacturers'
instruction. Images were captured using C-DiGit Blot Scanner (LI-COR,
USA). Densitometric analysis was performed using ImageJ software and
values were normalized with loading control (β-actin or GAPDH). Data
presented is a mean of 3 independent experiments.
2.6. Real-time PCR
For real-time reverse-transcription polymerase chain reaction
(qRT-PCR) analysis, RNA was isolated with the RNeasy kit (Qiagen
GmbH, Hilden, Germany). One microgram of total RNA was converted
to complementary DNA by Superscript III ﬁrst-strand synthesis system
(Invitrogen, CA, USA). cDNA template (5 ng)was used from each sample
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kit (Qiagen GmbH, Hilden, Germany) and primer (Supplementary
Table 1) as per the kit instructions. Samples were cycled with
RotorGene Q (Qiagen GmbH, Hilden, Germany) as follows: 5 min at
95 °C, followed by 40 cycles of 10 s at 95 °C and 30 s extension at
60 °C. All experiments were performed in triplicates. Relative quantiﬁ-
cation was calculated according to the ΔΔCt method for quantitative
real-time PCR (using an endogenous control gene, GAPDH). For each
gene, the expression at a speciﬁc day was then normalized by its base-
line values. Heat-mapswere generated fromnormalized Ct values using
Genesis software.2.7. Statistical analysis
Results were reported as mean ± standard error of mean (SEM).
Comparison between groups was performed using one-way ANOVA
followed by Tukey's post-hoc tests. p b 0.05 was considered statistically
signiﬁcant.Fig. 1.Wnt signaling in cardiac differentiation. A. Schematic representation of cardiac different
differentiation acrossmultiple hPSC lines. Bars represent mean± SEM of three independent ex
NKX2-5eGFP/w-hESC, LQTS2-hiPSC1.4, AF-hiPSC and BJ-iPSC during cardiac differentiation. Norm
D. Relative gene expression levels of Wnt3,Wnt3a and Wnt11 during cardiac differentiation.
cell lines. E. Whole mount EB staining from BJ-iPSC cell line for Wnt3 (green) and Wnt11 (red
F.: i,Western blot showingWnt3 andWnt11 levels at different days of differentiation alongwith
during differentiation. Bars representmean± SEMof three independent experiments. a–cmatc
matching symbols are statistically non-signiﬁcant at 95% conﬁdence limit for Wnt11.3. Results
3.1. Role of Wnts in cardiac differentiation
All hPSCs were maintained as feeder-free cultures. Colonymorphol-
ogy of these iPSCs was similar to hESC colonies in size and in nucleus/
cytoplasmic ratio. Immunoﬂuorescence staining showed strong nuclear
staining for Oct-4, Nanog (Supplementary Fig. 1) and various surface
embryonic antigens (SSEA4, Tra-1-60 and Tra-1-81) (Supplementary
Fig. 1), conﬁrming their pluripotency.
To maintain consistency of differentiation efﬁciency, we utilized an
embryoid body (EB) based protocol to recapitulate early cardiac devel-
opment that hinges on stage-speciﬁc activation and inhibition of Wnt/
β-catenin alongwith BMPmodulation as depicted in Fig. 1A. Evaluation
of contracting cardiomyocyte (CM) clusters on day 14 post differentia-
tion demonstrated high efﬁciencies across eight cell lines tested
(Fig. 1B). We next evaluated 15 members of the Wnt family to under-
stand their role during cardiac differentiation in 4 different pluripotent
stem cell lines. Our results indicated thatWnt2/2b,Wnt3/3a,Wnt5a/5biation from human pluripotent stem cells. B. Contracting efﬁciency post-day 14 of cardiac
periments. C. Heat map shows temporal expression of variousWnts across four hPSC lines;
alized Ct values were plotted, where lower Ct values indicate higher expression (green).
Note the signiﬁcant increase in Wnt11 levels post day 6 of differentiation across multiple
), counterstained with DAPI (blue) at different days of differentiation. Scale bar-200 μm.
loading control of beta-actin. ii, Densitometric analysis ofWnt3a and 11 expression levels
hing alphabets are statistically non-signiﬁcant at 95% conﬁdence limit forWnt3a. *,#, and ^
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with markers indicative of different phases of cardiac differentiation
(Fig. 1C; Supplementary Fig. 2). Wnt3/3a, a well-known member of
the canonical pathway, was signiﬁcantly up regulated in all cell lines
from days 1 to 4 (Fig. 1D) and their expression was signiﬁcantly
reduced post-day 4 (Fig. 1D). On the other hand, Wnt11, a non-
canonical regulator, was signiﬁcantly up regulated post days 6–8 in all
the tested cell lines and was highest on day 18 post-differentiation
(Fig. 1D). Similar to Wnt11, Wnt5a/5b was signiﬁcantly up regulated
post day 6 or 8 depending on the cell line, but their expression levels
were lower as compared toWnt11 (Fig. 1C).WhileWnt2/2b expression
levels were transient between days 4 and 8 in all lines, except in LQTS2-Fig. 2.Wnt activation modulates cardiomyocyte differentiation. A. Schematic representati
blots for Wnts (Wnt3a and Wnt11), Nkx2.5, cardiac troponin T and β-actin (loading cont
panel, densitometric analysis of Western blot post-CHIR treatment. Note the signiﬁcant
to respective control groups. Bars represent mean ± SEM of three independent experim
β-actin (loading control) on days 8 and 14 with and without Wnt11 treatment in LQTS2-h
Note the signiﬁcant up-regulation in cardiac markers (Nkx2.5, cTnT). *p b 0.05 compar
experiments. D. Contracting efﬁciency percentage post CHIR orWnt11 treatment on days 8
mean ± SEM of three independent experiments. E. Whole mount staining of day 8 EBs from
stained with DAPI (blue) post Wnt11 treatment. Scale bar: 100 μm.hiPSC1.4 (Fig. 1C), other members of the Wnt family were either
expressed at low levels or transiently and showed no speciﬁc trend
(Fig. 1C; Supplementary Fig. 2). In order to conﬁrm these gene expres-
sion results, immunostaining andWestern blots were performed at dif-
ferent stages of cardiac development in hPSCs. Two and 4 day old EBs
stained positive forWnt3a, whereas 6 and 8 day old EBs stained positive
for Wnt11 (Fig. 1E). Similar to immunostaining, Western blots showed
high protein levels of Wnt3a that peaked by day 4 while Wnt11 ap-
peared during later stages of differentiation (day 6–day 8; Fig. 1Fi–ii).
These results suggested a temporally activated tandem signaling of
canonical and non-canonical pathways in steering cardiac fate commit-
ment and lineage development.on of CHIR or Wnt11 treatment during cardiac differentiation. B. Top panel, Western
rol) on day 8 and 14 with and without CHIR treatment in NKX2-5eGFP/w hESC. Bottom
down-regulation of Wnt11 and cardiac markers (Nkx2.5, cTnT). *p b 0.05 compared
ents. C. Western blots for Wnts (Wnt3a and Wnt11), Nkx2.5, cardiac troponin T and
iPSC1.4. Bottom panel, densitometric analysis of Western blot post-Wnt11 treatment.
ed to respective control groups. Bars represent mean ± SEM of three independent
and 14. *p b 0.05 compared to respective control groups; n = 300 EBs. Bars represent
LQTS2-hiPSC1.4 showing co-expression of Nkx2.5 (red) and cTnT (green), counter-
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Based on the above initial data, we speculated that phasic regulation
of Wnts (canonical and non-canonical) may inﬂuence outcome of
cardiogenesis. In order to validate this hypothesis, we treated our
most efﬁcient PSC line (NKX2-5eGFP/w-hESCs), with a GSK3 inhibitor,
(CHIR99021,5 μM) that constitutively activates the beta-catenin/
canonical Wnt pathway. Alternatively, a less efﬁcient line, LQTS2-
hiPSC1.4 was treated with Wnt11 (50 μg/mL) that activates non-
canonical pathway from day 4 to day 8 of differentiation (Fig. 2A).
Western blot analysis showed CHIR99021 signiﬁcantly abrogated cardi-
ac differentiation with drastic reduction (about 90%) in cTnT and 50%
reduction in Nkx2.5 levels on day 8 and 14 in NKX2-5eGFP/w-hESC
(Fig. 2B). This was accompanied by a 5-fold and 2-fold enhancement
of Wnt3a protein on day 8 and 14, respectively (Fig. 2B). Contrary
to Wnt3a, a 20–25% reduction was observed inWnt11 expression levels
on day 8 and14 (Fig. 2B). Interestingly, treatmentwithWnt11 (50 μg/ml)
on LQTS2-hiPSC1.4 signiﬁcantly accentuated cardiac troponin (cTnT)
expression levels on day 8 that further increased by day 14 (Fig. 2C).
This coincidedwith 30% increase in Nkx2.5 levels on day 8 that supported
the enhanced expression of cTnT observed (Fig. 2C). While an increase of
Wnt11 on day 8 may be a result of exogenous Wnt11 treatment, thereFig. 3. Canonical Wnt activation promotes early cardiac mesoderm commitment. A. Tempor
mesodermal markers (T and Mesp1) in multiple cell lines. Note signiﬁcant up-regulation of th
experiments. B.Western blot analysis during various days of differentiation showing changes in
trol. Graphs represent densitometric analysis of these markers during differentiation. Bars rep
control groups (d0). Abbreviations: d—day. C. Whole mount staining of day 4 EBs from BJ-h
(blue). Scale bar: 50 μm.was amarked reduction inWnt3a levels on day 8 (Fig. 2C). Furthermore,
the over-activation of beta-catenin/canonical Wnt signaling due to treat-
mentwith CHIR99021 resulted in a signiﬁcant decrease in contracting ef-
ﬁciency in NKX2-5eGFP/w-hESCs. On the other hand, treatment of LQTS2-
hiPSC1.4 with Wnt11 signiﬁcantly increased the contracting efﬁciency
on day 14 (Fig. 2D). Immunostaining of EBs on day 8 further conﬁrmed
an increase, albeit regional enhanced cTnT expression following Wnt11
treatment (Fig. 2E).
3.3. Canonical Wnts modulate cardiac mesoderm commitment in hPSCs
In order to drive hPSC towards cardiac differentiation, a combination
of BMP4 and Activin A was utilized in the differentiation protocol. BMP4
with Activin A has been reported to commit EBs towards mesoderm
and cardiac fate. Our gene expression studies conﬁrmed that in the ab-
sence of exogenous BMP4 and Activin A (S1), commitment towards me-
sodermal lineage was delayed that coincided with a muted expression of
canonical Wnts (Supplementary Fig. 3). Interestingly, addition of BMP4
and Activin A potentiated canonical Wnts across multiple cell lines
(Fig. 3A). However, there were subtle differences in the days as well as
the expression level of canonical Wnts. These subtle differences were
also seen in the expression levels of T as well as Mesp1 during earlyal gene expression levels of Wnt 3/3a, pluripotency marker (Pou5f1) and early cardiac
ese markers by day 4 in all cell lines. Data represent mean ± SEM of three independent
Wnt3a, LRP6, Phospho-LRP6, Dvl2, Oct4, T and Mesp1 alongwith GAPDH as internal con-
resent mean ± SEM of three independent experiments. *p b 0.05 compared to respective
iPSC line shows co-expression of T (green) and Mesp1 (red), counterstained with DAPI
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instance, concomitant up regulation of Wnt3/3a along with T and Mesp1
was observed on day 2 in NKX2-5eGFP/w-hESCs, whereas similar correla-
tion was observed on day 4 with other cell lines (LQTS2-hiPSC1.4, AF-
hiPSC, BJ-hiPSC; Fig. 3A). On the other hand, Oct4, a pluripotency
transcriptional factor was down-regulated across all cell lines in gene
and protein expressions, indicating initiation of differentiation (Fig. 3A
and B). In order to validate these changes on the transcriptome level,
we arrayed a panel of markers of Wnt pathway and mesodermal/early
cardiac commitment markers byWestern blot (Fig. 3B). Our time kinetic
protein analysis indicated Wnt3/3a, disheveled 2 (Dvl2, important
intermediate of canonical Wnt signaling) and phosphorylated LRP6
(Ser1490) (co-receptors for Wnts and are required for the canonical
Wnt/β-catenin signaling) levels peaked on day 4 of differentiation
(Fig. 3B). Interestingly, early mesodermal and cardiac mesodermal
markers, T andMesp1 showedmaximumexpression on day 4 of differen-
tiation, similar to canonical Wnt markers (Fig. 3B). Our results also
demonstrated that expression of most of Wnt markers tapered post-day
4 peaking, indicating towards decreased canonical Wnt signaling
(Fig. 3B).Wholemount immunostainingof day4EBsdemonstratedoverall
expression of T andMesp1 (Fig. 3C). These results indicated that canonical
Wnt showed concomitant changes similar to early cardiac mesodermal
commitment during cardiac differentiation of pluripotent stem cells.Fig. 4. Temporal expression in cardiac progenitors and cardiomyocytes. A. Relative gene expre
markers (Tnnt2, Mlc2v, Mlc2a and Hcn4) across four hPSC lines. Note signiﬁcant increase in the
tiation. Data represent mean± SEM of three independent experiments. B. Representative who
(red) and cardiac troponin T (green), counterstainedwith DAPI (blue). Scale bar: 100 μm.Note l
Nkx2.5, cTnT, Titin, MLC2a, α-actinin, MLC2v and SERCA2a conﬁrming their phenotype at
Scale bar-50 μm.3.4. Non-canonical Wnts modulate cardiomyocyte speciﬁcation in hPSCs
We have shown that prolonged expression of canonical Wnt post
day 4 of differentiation (Fig. 2) could signiﬁcantly hinder cardiac differ-
entiation. Thus, we blocked canonical Wnt using a cocktail of speciﬁc
inhibitors, IWP4 (antagonist of the Wnt/β-catenin pathway), Noggin
(BMP blocker) and A83-01 (Activin/Nodal blocker) during the next
stage to differentiation (days 4–6). Addition of these inhibitors during
differentiation demonstrated signiﬁcant down-regulation of Mesp1,
Wnt3 and Wnt3a gene expression levels (Supplementary Fig. 3).
Down-regulation of canonical Wnts (Wnt3/Wnt3a) was followed
by an up-regulation of Wnt11 (non-canonical member) and Isl1 levels
(Supplementary Fig. 3). However, the up-regulation of cardiac
committed makers including Nkx2.5 was not consistent in repeated
experiments (n = 3) and their levels remained relatively low
(Supplementary Fig. 3). Therefore, we supplemented VEGF to promote
proliferation of Nkx2.5 positive cardiac progenitors [19,27], resulting in
a concomitant increase in Wnt11 and Nkx2.5 levels (Supplementary
Fig. 3). However, prolonged addition of Noggin (for 4 days) until day
8, down-regulated cardiac speciﬁcation (Nkx2.5 and GATA4) along
with Wnt11, but up-regulated neuroectodermal markers (Nes and
Pax6) together with Wnt3 (Supplementary Fig. 3). Hence, Noggin was
omitted after day 6 in the ﬁnal stages of differentiation.ssion of Wnt11, cardiac progenitor markers (Nkx2.5, Gata4 and Irx4) and mature cardiac
expression of progenitor markers post-day 6 and mature markers post-day 8 of differen-
le mount staining of day 8 EBs from LQTS2-hiPSC1.4 line showing co-expression of Nkx2.5
imited expression of troponin T in day 8 EBs. C. Immunostaining of various cardiacmarkers,
day 20 of differentiation. Note the presence of I-and A-bands in the cardiomyocytes.
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effectively enhanced Wnt11 levels across multiple cell lines (Fig. 4A).
Concomitant to this increased Wnt11, an increase was also observed
in cardiac-associated transcriptional factors, Nkx2.5, Gata4 and Irx4 on
day 6 post-differentiation (Fig. 4A). However, slight variations were
observed with various cell lines. For instance, LQTS2-hiPSC1.4 and AF-
hiPSC expressed high levels of Nkx2.5 (more than 1,000 folds), whereas
NKX2-5eGFP/w-hESCs expressed moderate levels (200–500 folds) of
Nkx2.5 (Fig. 4A). Similarly, LQTS2-hiPSC1.4 expressed low levels of Irx4
whereasNKX2-5eGFP/w-hESCs expressed high levels of Irx4 (Fig. 4A). Con-
comitant with the expression of early cardiac transcriptional factors,
there was a signiﬁcant up-regulation in the expression patterns of
cardiac-speciﬁc structural and sarcomeric proteins post day 6 of differen-
tiation.Whilemyosin light chain 2a (Myl7) was detected as early as days
4–6 during differentiation, their expression levels were low (Fig. 4A).
However, post day 6 of differentiation, cardiac troponin T (Tnnt2) follow-
ed by myosin light chain 2v (Myl2) was signiﬁcantly up regulated in
most of the cell lines (Fig. 4A). However, a drastic decrease inMyl7 levels
in NKX2-5eGFP/w-hESCs post day 14 differentiation was observed
(Fig. 4A). Gene expression for the HCN4 ion channel was signiﬁcantly
up regulated by day 14 of differentiation (Fig. 4A).Fig. 5.Wnt11 accentuates development of cardiomyocytes. A.Western blot analysis during vario
cTnT along with GAPDH as internal control. Graphs represent densitometric analysis of these
ments. *p b 0.05 compared to respective control groups (d0). B. Flow cytometric analysis of da
than 90% of the population expresses Nkx2.5with limited troponin T. Bottom panel,ﬂowcytom
alongwithNKx2.5. A total of 10,000 eventswere analyzed. C. Heatmap shows temporal express
and BJ-iPSC. Normalized Ct values were plotted, where lower Ct values indicate higher expressWe also performed immunostaining of day 8 EBs that stained posi-
tively for Nkx2.5 (red) throughout with weak localized cTnT (b10%;
green) staining (Fig. 4B). Moreover, CMs derived by this differentiation
stained positive for cardiac structural and ion channel proteins; cardiac
actinin, titin, MLC2v/MLC2a and SERCA2a by day 20 of differentiation
(Fig. 4C). Dual staining on differentiated CMs showed nearly all cells
to be positive for Nkx2.5 (red, No. of Nkx2.5+/DAPI+: 652/670) with
most of them being also positive for cTnT+ (green, No. of cTnT+/
DAPI+: 467/670) in LQTS2-hiPSC1.4 cell line (our less cardiac efﬁcient
line). Interestingly, positively stained CMs demonstrated an immature
striated pattern indicating early stages of myocyte development.
However, Z-bands and A-bands were clearly visible in these CMs
(Fig. 4C; Supplementary Fig. 4).
Since our data (Fig. 3) demonstrated amarked reduction in canonical
signaling post-day 4 of differentiation, we evaluated the role of non-
canonical Wnt pathway. Our Western blot results indicated that non-
canonical Wnts; Wnt11 and Wnt5a/b were signiﬁcantly expressed post
days 6–8 of cardiac differentiation (Fig. 5A). However, Wnt5a/5b had a
biphasic role as it peaked on day 4 as well as day 14 of differentiation
(Fig. 5A). Moreover, we also evaluated other members of Wnt family,
Naked2 (inhibits the canonical Wnt/β-catenin pathway) and disheveledus days of differentiation showing changes inWnt11,Wnt5a/5b, Naked2, Dvl3, Nkx2.5 and
markers during differentiation. Bars represent mean ± SEM of three independent experi-
y 8 EBs (top panel) shows cells expressing Nkx2.5/cTnT in representative cell lines. More
etric analysis of day 18myocytes showa signiﬁcant increase in cardiac troponin expression
ion of cardiac ontogeny across four PSC lines,NKX2-5eGFP/w-hESC, LQTS2-hiPSC1.4, AF-hiPSC
ion (green).
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with Dvl3 indicating signiﬁcant reduction of canonical signaling and
functionally active non-canonical signaling during the later stages of car-
diac differentiation (Fig. 5A). This increase of non-canonical signaling
correlated with simultaneous increase in NKx2.5 and cardiac troponin
(cTnT) levels (Fig. 5A).
Moreover, ﬂow cytometric analysis on day 8 EBs showed that N90%
of cells were SIRPA+ (Supplementary Fig. 5) and Nkx2.5+ (Fig. 5B, top
panel) with low levels of cTnT+ cells (N7%). However, only BJ-hiPSC
line showed a moderate level of NKx2.5+/cTnT+ cells on day 8 (33.4 ±
4.74%, Lane 6, Supplementary Fig. 5). Flow cytometric analysis on day
18 of CMs revealed that Nkx2.5+/cTnT+ dual positive populations
(Fig. 5B, lower panel) ranged between 65 and 95% with NKX2-5eGFP/w
hESCs, AF-hiPSC and BJ-iPSC (Supplementary Fig. 5) producing the
highest percentage of cTnT+/Nkx2.5+ (N90%) while only LQTS2-
hiPSC1.3 and LQTS2-hiPSC1.4 showed relatively lower efﬁciency
(67.4± 4.7%, 64.7± 4.0%, n=3) (Supplementary Fig. 5). Nevertheless,
temporal proﬁling of gene expression during our directed differentia-
tion regime conﬁrmed orderly ontogeny of cardiac developmental
program from cardiomesoderm (Mesp1) to cardiac progenitors
(e.g Isl1, c-kit, Kdr, Sirpa,Nkx2.5) and subsequently cardiac speciﬁcation
(e.g Tbx5, Nrf2f, Irx4, Shox2) towards ﬁnal cardiomyocyte commitment
(e.gMLC2a,MLC2v, HCN4) (Fig. 5C). These results collectively indicated
that phasic changes in Wnt signaling (canonical and non-canonical)
correlated well with changes in early and late (committed) cardiac
marker expressions, suggesting their probable involvement during
cardiac differentiation.4. Discussion
Cardiac development is a highly inter-connected process that is
cross regulated by families of signaling factors [28–30]. Although
cardiomyocytes (CMs) have been successfully generated from mouse
and human pluripotent stem cells (hPSC) in vitro, intra- and inter-line
variation in differentiation towards CMs vary substantially. This
variability has been linked to intrinsic differentiation biases of hPSC
lines and their inherent responsiveness towards cardiac inducing fac-
tors [2,3,20] during cardiac commitment and differentiation. In this
study, we attempted to circumvent such intra- and inter-line variations
with hPSCs generated fromhealthy and disease origin thatwere created
via viral or non-viral techniques. Thereupon we evaluated if phasic
modulation of Wnts (canonical and non-canonical) could signiﬁcantly
enhance cardiac differentiation across multiple hPSC lines. We showed
that phasicmodulation ofWnt signaling could overcome intrinsic biases
of hPSCs that obviated mandatory cell line-speciﬁc titration of inducing
factors for efﬁcient cardiac differentiation.
Mesodermal commitment is highly dependent on interactions
between the BMP/Nodal/Wnt signaling pathways. We showed that ad-
dition of Activin A (surrogate for Nodal signaling [11]) with BMP4 not
only enhanced expression of the pan-mesodermal marker Brachyury
(T), but also enhanced endogenous canonicalWnt (Wnt3 and 3a) levels
during fate determination. Furthermore, it was noted that Pou4f1 levels
persisted till day 4, followed by a steep decline. We and others have
previously demonstrated that gradual loss of Oct4 during early stages
of differentiation beneﬁted mesendodermal commitment [3,31,32].
The presence of Oct4 along with canonical Wnts during early phase of
cardiac differentiation, activates the Tcf\Lef-Oct4 composite element
regulating expression of cardiogenic factor, Mesp1 [33]. Consistently,
our immunostaining of day 4 EBs post Wnt3/3a activation showed
signiﬁcant expression of T andMesp1 conﬁrmingmesodermal commit-
ment and patterning towards cardiac mesoderm. These results indicat-
ed that activated endogenousWnt3/3a signaling occurred concurrently
with cardiac mesodermal commitment. However, we observed marked
differences in the canonicalWnt levels during the initial 3–4 days of dif-
ferentiation in each hPSC line studied. This may be a result of inherentvariations between hPSC lines, however these variations did not affect
cardiac differentiation efﬁciencies (Fig. 1B).
Previous studies revealed that canonicalWnt signaling is essential for
early stages of cardiac commitment towards Mesp1 cardiomesoderm
[34], however its prolonged activation inhibits further cardiac differenti-
ation [35,36]. Moreover, these studies show that down-regulation of
canonical Wnt levels is necessary to progressively commit Mesp1+
cells towards cardiac differentiation. Our results support these studies
as inhibition of canonical Wnts by the inhibitor cocktail resulted in a
signiﬁcant increase in non-canonical Wnt levels leading to cardiac com-
mitment as assessed by expression of cardiac transcriptional, structural
and ion channel proteins (Figs. 4–5).
Loss of function and overexpression studies of Wnt11 have revealed
its critical role in normal heart development and cardiac activity [37–39].
Consistently, post Mesp1 induction (day 4), addition of exogenous
Wnt11 to our inherently less cardiac efﬁcient line (LQTS2-hiPSC1.4,
Fig. 2C) enhanced cTnT expression and increased beating efﬁciency
(Fig. 2D) that corresponded with increased channeling of cardiac pro-
genitors towards cardiomyocytes. Alternatively, addition of CHIR99021,
a GSK3β inhibitor, beyond the early commitment stage in our most
efﬁcient cardiac line (NKX2-5eGFP/w hESCs) abrogated cardiomyocyte
generation (Fig. 2B, D) by substantiating activation of canonical Wnt
(Wnt3a) pathway. Furthermore, during monolayer differentiation of
NKX2-5eGFP/w-hESCs, failure to up-regulate the non-canonical Wnt
pathway led to an inefﬁcient switching of cardiomesoderm to cardiac
progenitors (Nkx2.5 expressing cells), reinforcing the importance of
tandem signaling relays among Wnt family members (Supplementary
Fig. 6). Apart from Wnt11, Wnt5a/b has been reported to play a dual
role in both canonical and non-canonical Wnt signaling [12]. Consis-
tently, we observed that Wnt5a/b emerged on both day 4 and day 14
post differentiation when cardiac mesoderm commitment (Mesp1 up
regulated) and cardiomyocyte speciﬁcation (cTnT up regulated) took
place respectively. It has also been reported thatWnt5a/b has the ability
to shunt Dvl3 into the planer cell polarity pathway (non-canonical
pathway) [40,41], which is consistent with our data, as Dvl3 gradually
increased throughout cardiac differentiation. Collectively, this con-
ﬁrmed that canonical/non-canonical Wnt axis may play an important
role during cardiac differentiation and could be important for early
cardiac commitment (Mesp1 expressing cells) and cardiomyocyte spec-
iﬁcation (cTnT expressing cells). It has also been previously shown in
Xenopus development that Wnt11 and Wnt5a interact physically [42]
through tyrosyl protein sulfotransferase-1-dependent O-sulfation [43]
and can induce β-catenin signaling. We observed recurrence of Wnt3a
expression on day 14 post differentiation (Fig. 3B). This late resurgence
of canonicalWnt pathway/β-catenin signalingwhichmay be important
for proliferation of cardiac progenitors are yet to be converted to
cardiomyocytes. This was corroborated by similar re-emergence of
Mesp1 at day 14 of differentiation (Fig. 3B), which is in agreement
with previous studies demonstrating that re-activation of canonical
Wnts could induce cardiomyocyte proliferation [44]. Interestingly,
thoughWnt3a recurred on day 14 post differentiation, canonical signal-
ing via LRP6 did not take place as evidenced by decreased phosphoryla-
tion and reduction in Dvl2 (Fig. 3B).5. Conclusions
In summary, phasic modulation of Wnt axis signiﬁcantly enhanced
cardiac differentiation (N75% cTnT+) in normal and patient derived
hiPSC lines generated through viral, episomal and mRNA based tech-
niques. By modulating Wnt signaling, cardiac developmental ontogeny
was recapitulated across 8 hPSC lines independent of inherent differen-
tiation biases or responsiveness to induction factors. Understanding the
intricacy of Wnt signaling in cardiogenesis would capitalize directed
cardiac differentiation of patient-derived hPSCs to realize clinical poten-
tial of personalized regenerative medicine.
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